Select Committee on Environment, Food and Rural Affairs Minutes of Evidence


Examination of Witnesses (Questions 320 - 332)

MONDAY 15 OCTOBER 2007

PROFESSOR DOUGLAS YOUNG AND PROFESSOR GLYN HEWINSON

  Q320  Mrs Moon: You talked about needing a magic bullet and we accept there is not going to be a magic bullet. I think we have moved on. Although I take the Chairman's point about Edward Jenner, it did work and it was wonderful. Realistically, given that things mutate, even BCG in humans is facing a challenge of new strains, do you have in your head a level of efficacy that actually would mean that you think this is a level that makes it something we have to do? Is 50% good enough? Is 60% good enough? Do you have that central figure of efficacy that you would be looking for as a guideline?

  Professor Young: We need to have some sort of policy. How we are going to use it you would need to think about before you set that number, what you mean by 50%. Does that mean 50% of the animals would have no bacteria in them whatsoever or all of the animals would have 50%?

  Q321  Mrs Moon: 50% less episodes of cattle needing to be destroyed. I was thinking about the long term. Realistically we are looking at a huge economic cost to the farming industry. That is what this is all about. This is not about "Poor badgers, they have TB, we must sort that out"; this is about a huge impact on our farming industry. If we can cut TB slaughter of cattle by 50%, would that be good enough?

  Professor Young: That is a policy question and I think that is what they are working with. Policy people with Defra are trying to work that through. It has been silly the way we have had it before that the researchers were supposed to come up with that view. There has to be a pragmatic cost-effective policy view that you then feed back into your experimental design and set the end point.

  Q322  Mrs Moon: We also have to know how efficient you think your product is going to be. If we do not know that it is effective in at least 60 or 70% of badgers, we cannot then extrapolate into what the potential impact is going to be on cattle. Are you going to be able to come up with some sort of awareness or figure that will let us have some idea of how effective you think it will be in terms of the overall population of badgers, bearing in mind that if we are going for a baiting trial we are going to miss some?

  Professor Young: We will come up with some number. From the under experimental conditions, we will come up with a hard number from there and it will be something like 70%.

  Professor Hewinson: There are a couple of things I feel need doing apart from the science and one is this clear product profile: what do we need, what are we aiming for. I think you are absolutely right there. The second thing is a manufacturer and supplier, someone who is going to hold the licence. Those are absolutely critical.

  Q323  Mr Drew: We will not say where; it is a sore point.

  Professor Hewinson: The other thing I would say in terms of trying to define how effective the vaccines are, as we talked about earlier, hopefully some of this field trial will give us some indication of how effective the vaccine will be in badgers. We have a natural transmission experiment in cattle where we have infected animals and we introduce vaccinated and non-vaccinated cattle into that herd of reactor animals to get some idea of how effective it is.

  Q324  Mr Drew: Are we are actually vaccinating cattle that have been infected by bovine TB who are suffering at the moment?

  Professor Hewinson: No. We are vaccinating animals and introducing them into contact with infected animals.

  Q325  Mr Drew: There is no point in vaccinating an animal who already has bovine TB?

  Professor Hewinson: No.

  Q326  Mr Drew: Is that because of choice or because you are not allowed to because under the current arrangements an animal that has bovine TB should be removed?

  Professor Hewinson: There is very little evidence I have seen of therapeutic vaccines. This is one of the big goals for human vaccine work.

  Q327  Mr Drew: Do we vaccinate humans who have TB?

  Professor Hewinson: No, we treat them with antibiotics.

  Q328  Mr Drew: But we then would subsequently vaccinate them?

  Professor Young: No. There is no evidence that BCG does anything if you have TB.

  Q329  Mr Drew: That is why we need to work on other vaccines.

  Professor Young: That is why we give them very early before you see TB.

  Q330  Mr Drew: I thought we still gave them some BCG. We will take that as the final word. That was an interesting conclusion. What you have said cannot be unsaid. We may take subsequent evidence from you. This is an interesting topic and certainly a topic that has to give us some answers some time because we cannot go on the way we have been going. I thank you for your evidence. It is good the Minister has sat all the way through this session as we will be asking questions of him subsequently. It has been very helpful and I thank you for being so succinct because we have kept to just over our hour and we have some interesting results. Presumably if we wanted to gain more front-end understanding of how this is working, in the same way as I saw the presentation on the badger vaccine trial, you would be very happy to give us something. Could you do the two side by side? I found the one that took us through how the trials were actually working very helpful because just listening to you talking about it is not the same as having someone do a presentation.

  Professor Hewinson: It might be very useful to come and visit us at VLA to see the scope of what is really required in doing these things. That puts it in context in a way that really allows you to see in a much better way the scope of what is involved.

  Q331  Mr Drew: I take that as an invitation that we would be pretty daft not to follow up on.

  Professor Young: You can come and sit in our territory where we would be very much more relaxed.

  Q332  Mr Drew: Knowing how time is limited, could we put the things together and see if we could do a couple of presentations on cattle, badgers, even if we would like to cross-mesh them sometime in the future?

  Professor Hewinson: Yes. Can I say one other thing on the time lines? We have put those together and we feel those are realistic. Those are best case scenarios if everything goes well but best laid plans of mice and men, and foot and mouth—

  Mr Drew: We are not bringing mice into this! Cattle and badgers are enough for us.





 
previous page contents

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2008
Prepared 27 February 2008